In Clinical Trials, Look to the East
This article was originally published in Start Up
Executive Summary
Untapped and treatment naive patients in emerging countries in Central and Eastern Europe offer pharmaceutical companies the opportunity to speed up clinical trials and avoid perhaps the largest cost in drug development: delay in reaching the market. CROs, too, see the EEC as the newest large growth opportunity.